Lunar New Year travellers try to outsmart algorithms for cheaper fares
The trick? Fool the algorithms, according to Lan.
Before Lan booked her flight, she unleashed a string of social media posts complaining about costly holiday airfares. 'I'm not going because flight tickets are too expensive,' she wrote, singling out some of China's most widely used travel booking platforms. 'Look at me, Qunar, Trip.com, Tongcheng, Fliggy: I'll uninstall you all if you keep increasing the price.'
Five days after, Lan said she found the cost of her desired ticket went down by more than half from 1,200 yuan. Qunar, Trip.com , Tongcheng and Fliggy did not respond to requests for comment. Fliggy is operated by Alibaba Group Holding, owner of the South China Morning Post. Travellers at Beijing Capital International Airport. Photo: AFP
Lan is among a growing number of Chinese internet users who are looking for ways to fight what they describe as Big Data-enabled discrimination. They believe that online platforms charge existing customers and frequent visitors higher prices, and occasionally withhold discounts from them.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
43 minutes ago
- South China Morning Post
China to amend key law as push to stamp out vicious price wars intensifies
China plans to amend a decades-old pricing law as part of an ongoing campaign to curb the vicious price wars plaguing several industries – a deep-rooted issue that threatens to wipe out corporate profits and fuel deflationary pressure. The amendment, which covers 10 clauses in the law, updates the definition of unfair pricing practices to include 'involution-style' competition, according to a draft released by China's National Development and Reform Commission (NDRC) and the State Administration for Market Regulation on Thursday. The term 'involution' has become a buzzword in China that refers to the excessive, cutthroat style of competition that has emerged in several industries, as companies facing weak domestic demand and oversupply problems slash prices in a bid to attract customers. The trend has become a serious concern for Beijing in recent months, with Chinese officials repeatedly vowing to stamp out the price wars and criticising companies that engage in 'disorderly' styles of competition that risk undermining economic growth. As China's economic landscape had undergone profound changes, the pricing law that originally came into effect in 1998 needed to be updated, government agencies said in a statement. 'With new economic forms and business models continuing to emerge, some industries have seen prominent cases of disorderly low-price competition, creating new demand for price regulation and oversight,' the statement said. The amendment, which is open for public comment until August 23, adds a new clause stating that businesses shall not force other operators to dump products at below-cost prices. Previously, the law only banned firms from selling goods below cost to eliminate competitors or monopolise the market.
South China Morning Post
an hour ago
- South China Morning Post
How China's open-source movement changed the landscape of AI
Date and time: Thursday, August 7, 2025 10.30-11.30am (HKT) The webinar will be live-streamed on this page. Bookmark it or add the event to your calendar to stay informed. Submit your questions to the panel and get them answered during the webinar. A fundamental shift challenging Silicon Valley's dominance is under way, driven by Chinese tech titans such as DeepSeek, Moonshot, Alibaba, Baidu and Tencent. This collaborative open-source AI revolution presents unprecedented opportunities with direct impacts on businesses, the global economy, the technological landscape and workforce dynamics. Alibaba owns the South China Morning Post. The South China Morning Post is proud to host an exclusive webinar to explore how this dynamic shift is transforming the landscape. Submit your questions for our panel to answer during the webinar. Our expert panellists will dive into pressing questions such as: Is China's open-source movement a direct response to US tech restrictions? How do Chinese models stack up against Western ones? What is the role of government backing? What are the business implications? Are there concerns about data security? The live-streamed webinar will be available to all logged-in SCMP readers. Our speakers will also engage in a Q&A session.
South China Morning Post
2 hours ago
- South China Morning Post
Pfizer, Chinese biotech firm 3SBio complete worldwide licensing deal for cancer drug
First announced in May, the deal will see 3SBio – based in Shenyang, capital of northeastern Liaoning province – receive a US$1.25 billion upfront payment from Pfizer for the exclusive right to sell its cancer drug, SSGJ-707, outside China. Under the terms of their agreement, Pfizer will also pay 3SBio up to US$150 million to solely develop and commercialise SSGJ-707 within the mainland, the two companies said on Thursday. Pfizer also agreed to buy 31.1 million new shares in S3Bio, or a 1.3 per cent equity stake, for HK$785 million, according to a stock exchange filing. The deal at HK$25.2055 per share represents a 17 per cent discount to its market price on Thursday. 3SBio's shares fell 6.41 per cent to HK$28.45 on Friday. The transaction reflected the strong momentum of Chinese biotech firms in the field of drugs research and the increased interest from major foreign pharmaceutical companies to license their intellectual property.
